🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07664371
Recruiting Not applicable

Cryoneurolysis Versus Radiofrequency in Knee Osteoarthritis

NCT07664371 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-06-10
Last updated
2026-08-11

Condition(s) studied

Knee Osteoarthritis

Investigational drug(s) / intervention(s)

Cryoneurolysispulsed radiofrequency (RF)cooled radiofrequency

Cryoneurolysis: Cryoneurolysis freezes nerves

pulsed radiofrequency (RF): radiofrequency (RF) uses electric pulses

cooled radiofrequency: uses cooled radiofrequency energy to deactivate pain-causing nerves

Study summary

The project will evaluate the effectiveness of Cryoneurolysis versus radiofrequency procedures in adult patients who are resistant to traditional treatment for knee pain. They are a drug-free pain management procedure.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Adults with a clinical diagnosis of refractory knee OA who suffered from refractory knee pain (patients who had failed conservative medical and physical therapy for 6 months . Exclusion Criteria: 1. Patients with OA show improvement in pain after conservative medical and physical therapy. 2. Patients evaluated by an orthopedic surgeon and deemed to be surgical candidates due to knee pathologies other than OA. 3. Patients with allergies to local anesthetics. 4. patients on anticoagulation therapy, who were not permitted to stop anticoagulation. 5. Patients with knee tumors. 6. Patients with acute infections. 7. Patients with implanted cardiac devices. 8. Pregnant patients.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of medicine, Tanta University Tanta Egypt Recruiting

More Tanta University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07664371 on ClinicalTrials.gov ↗ ← All trials in Egypt